{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 470617807
| IUPAC_name = (3''R'',5''R'',6''R'',7''S'',8''R'',11''R'',12''S'',13''R'',14''S'',15''S'')-12-[(4-''O''-acetyl-2,6-dideoxy-3-''O''-methyl-α-<small>L</small>-''arabino''-hexopyranosyl)oxy]-14-{[2-''O''-acetyl-3,4,6-trideoxy-3-(dimethylamino)-β-<small>D</small>-''xylo''-hexopyranosyl]oxy}-5,7,8,11,13,15-hexamethyl-4,10-dioxo-1,9-dioxaspiro[2.13]hexadec-6-yl acetate
| image = troleandomycin.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|MTM|troleandomycin}}
| MedlinePlus = a604026
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 2751-09-9
| ATC_prefix = J01
| ATC_suffix = FA08
| PubChem = 5284630
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01361
| ChEBI_Ref = {{ebicite|changed|EBI}} 
| ChEBI = 45735
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4447675
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = C4DZ64560D
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D01322
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 564085

<!--Chemical data-->
| C=41 | H=67 | N=1 | O=15 
| molecular_weight = 813.968 g/mol
| smiles = O=C(O[C@@H]4[C@@H](N(C)C)C[C@H](O[C@H]4O[C@@H]3[C@H]([C@H](O[C@@H]1O[C@H]([C@H](OC(=O)C)[C@@H](OC)C1)C)[C@H](C(=O)O[C@H](C)[C@H](C)[C@H](OC(=O)C)[C@H](C(=O)[C@]2(OC2)C[C@@H]3C)C)C)C)C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C41H67NO15/c1-19-17-41(18-49-41)38(46)23(5)34(53-27(9)43)21(3)25(7)52-39(47)24(6)35(56-32-16-31(48-14)36(26(8)51-32)54-28(10)44)22(4)33(19)57-40-37(55-29(11)45)30(42(12)13)15-20(2)50-40/h19-26,30-37,40H,15-18H2,1-14H3/t19-,20+,21-,22+,23+,24+,25+,26-,30-,31-,32-,33-,34-,35-,36-,37+,40-,41-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = LQCLVBQBTUVCEQ-MCQAQMIOSA-N
}}

'''Troleandomycin''' is a [[macrolide]] antibiotic. It is sold in [[Italy]] (branded '''Triocetin''') and [[Turkey]] (branded '''Tekmisin''').

Troleandomycin is a [[CYP3A4]] [[enzyme inhibitor|inhibitor]] that may cause [[drug interaction]]s.

==References==
{{Reflist|2}}


{{Macrolides, lincosamides and streptogramins}}
{{Xenobiotic-sensing receptor modulators}}

[[Category:Macrolide antibiotics]]
[[Category:Epoxides]]
[[Category:Spiro compounds]]
[[Category:Acetate esters]]

{{antibiotic-stub}}